Article Text
PDFImage of the moment
Erdheim-Chester disease presenting as precipitous cognitive decline
Statistics from Altmetric.com
Footnotes
Contributors SD and RP contributed equally to this paper.Conception of report: SD, RP, HB and EA. Drafting of manuscript: SD, RP, HB and AC. Contribution of relevant expertise for inclusion in manuscript: HB, MF, SJ, RA, ZT, MH, EA and AC. Critical review of manuscript for intellectual content: SD, RP, HB, MF, MH and EA. All listed authors were involved in the care of the patient listed.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned. Externally peer reviewed by Johann Selvarajah, Glasgow, UK.
Read the full text or download the PDF:
Other content recommended for you
- An unusual case of interstitial lung disease in a patient with cardiopulmonary syndrome as the initial presentation of Erdheim-Chester disease
- Peritoneal or mesenteric tumours revealing histiocytosis
- Erdheim-Chester disease: a rare cause of bilateral renal artery stenosis, mimicking large vessel vasculitis
- 4CPS-122 Efficacy and safety of cobimetinib used in monotherapy for erdheim–chester disease
- Efficacy of infliximab in the treatment of Erdheim-Chester disease
- The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases
- Erdheim-Chester disease: an unusual aetiology of bilateral lipomatous perinephric masses
- Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions
- Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib
- Erdheim-Chester disease with isolated craniocerebral involvement